In healthcare investments, targeting tech-enabled chronic care management and optimizing supply chain efficiency is key.
In this episode, Ian Wijaya, co-head of North America Healthcare at Lazard, delves into the dynamic tech-enabled services market within healthcare, exploring how strategic buyers and private equity firms are investing in businesses that can thrive through economic cycles. Ian provides an incisive analysis of the state of healthcare investments, emphasizing the importance of addressing unmet needs in large, clearly identifiable markets and achieving sustainable unit economics as well as operating leverage. He gets into the specifics, from chronic care management to precision medicine, and discusses the potential for real money-making opportunities in the health tech space over the next five years. Further, Ian navigates through the barriers to deal-making and the role of AI in creating monetizable business models and exits in healthcare.
Stay tuned for an enlightening conversation full of insights on the pulse of the healthcare market, the power of tech-enabled solutions, and the future of investment in healthcare innovation.
About Ian Wijaya:
Ian Wijaya is the Co-Head of Lazard’s North America Healthcare practice. Ian joined Lazard in 2011 and co-founded the Firm’s healthcare services practice, with a focus on M&A, strategic advisory, and recapitalization advisory for managed care insurance payers, providers across the continuum of care (e.g., acute care hospitals, ambulatory surgery centers, post-acute care, etc.), PBMs, distributors, payor and provider services companies, HCIT, and digital health companies.
Ian is a member of Lazard’s Opinion Committee and the World Economic Forum’s Global Future Council on Healthcare, as well as a Corporate Leader on the Council on Foreign Relations.
Ian has advised on more than $250 billion of corporate finance transactions, including mergers and acquisitions, leveraged buyouts, financial restructurings and reorganizations, joint ventures, and other matters, and has advised on several of the largest and most transformative M&A transactions in healthcare, including three of the largest in recent history.
Prior to joining Lazard, Ian was an investment banker at Greenhill & Co. in New York, where he focused on healthcare M&A but also provided M&A advice to companies in the technology and retail sectors. Prior to Greenhill & Co., he worked in the Investment Banking Division of Goldman Sachs & Co. and the financial restructuring group of Houlihan Lokey in New York.
Ian has an M.B.A. in Finance and Strategy from Northwestern University’s Kellogg School of Management and a B.A. (cum laude) from Dartmouth College.
Things You’ll Learn:
- The candid examination of market barriers and what it takes to finalize deals in turbulent times.
- The healthcare tech market demands investments in businesses with sustainable unit economics and the potential for operating leverage, promoting a balance between profit and growth.
- Strategic buyers and private equity are looking for healthcare services that can enhance supply chain visibility, manage costs efficiently, and improve patient outcomes through tech-enabled solutions.
- AI stands poised to revolutionize healthcare across several domains, with an emphasis on clinical decision support, population health management, and automation of administrative tasks.
- AI in healthcare will likely boom in 3 areas: clinical support, population health management, and operational automation.
Resources:
FEATURING
Ian WijayaHead of North America Healthcare Services M&A, Lazard
